Earnings Call · Q4 FY2022·2023-02-28

Q4 22EPS -36.76%·Rev n/aQ3 22EPS +13.04%·Rev n/aQ2 22EPS -51.72%·Rev n/aQ1 22EPS -4.44%·Rev n/a⚠ consensus missing

SUPERNUS PHARMACEUTICALS, INC. SUPN

−0.8%1d on move date−1.1% vs SPY3d−1.1%5d−0.9%

Research tier

Behavioral profile computed for this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SUPN calls or request research access.

More SUPN calls Browse calls Request research access